Xeriant, Inc.: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 15, 2026 and accepted by EDGAR at May 15, 2026, 16:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2026-01-01 to 2026-03-31 | $29.6k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2025-07-01 to 2026-03-31 | $99.9k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | −$350.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2025-07-01 to 2026-03-31 | −$885.8k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $45.6k | us-gaap:InterestExpense |
| Interest expense | 9 months2025-07-01 to 2026-03-31 | $126.2k | us-gaap:InterestExpense |
| Income tax | 3 months2026-01-01 to 2026-03-31 | −$24.2k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2025-07-01 to 2026-03-31 | $84.5k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | −$419.4k | us-gaap:NetIncomeLoss |
| Net income | 9 months2025-07-01 to 2026-03-31 | $1.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2025-07-01 to 2026-03-31 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2025-07-01 to 2026-03-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 882,172,810 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2025-07-01 to 2026-03-31 | 1,749,640,177 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2025-07-01 to 2026-03-31 | −$607.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2025-07-01 to 2026-03-31 | $3.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2026-03-31 | $33.8k | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $43.8k | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $5.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $5.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | −$2.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-26-003234. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.